SEVENTEEN YEARS EXPERIENCE OF EBRT PLUS HDR BRACHYTHERAPY BOOST IN HIGH-RISK LOCALIZED PROSTATE CANCER PATIENTS: A COMPETING RISKS ANALYSIS

被引：0
|
作者：
Carignan, Damien [1 ]
Despres, Philippe [1 ]
Magnan, Sindy [2 ]
Froment, Marie-Anne [2 ]
Foster, William [2 ]
Aubin, Sylviane [2 ]
Lavallee, Marie-Claude [2 ]
Lacroix, Frederic [2 ]
Cantin, Audrey [2 ]
Poulin, Eric [2 ]
Martin, Andre-Guy [2 ]
Vigneault, Eric [2 ]
机构：
[1] Univ Laval, Quebec City, PQ, Canada
[2] Univ Laval, CHU Quebec, Quebec City, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 150卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页码：S9 / 510
页数：2
相关论文
共 50 条
  • [1] 17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients
    Vigneault, E.
    Carignan, D.
    Magnan, S.
    Froment, M.
    Foster, W.
    Aubin, S.
    Lavallee, M.
    Lacroix, F.
    Cantin, A.
    Poulin, E.
    Martin, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S69 - S70
  • [2] THE ROLE OF CAPRA SCORE AS A PREDICTOR OF OUTCOMES IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH EBRT PLUS HDR BRACHYTHERAPY BOOST
    Vigneault, Eric
    Carignan, Damien
    Magnan, Sindy
    Despres, Philippe
    Martin, Andre-Guy
    Foster, William
    Lavallee, Marie-Claude
    Aubin, Sylviane
    Lacroix, Frederic
    Froment, Marie-Anne
    Cantin, Audrey
    Poulin, Eric
    Morales, Brandon
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S65 - S65
  • [3] Population outcomes of EBRT with LDR brachytherapy boost for intermediate, high-risk prostate cancer
    Oh, J.
    Spadinger, I.
    Lapointe, V.
    Morris, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S372 - S372
  • [4] HDR brachytherapy for high-risk prostate cancer
    Lo, TCM
    Bouyounes, BT
    Goodman, N
    Bihrle, W
    Roth, RA
    [J]. CANCER JOURNAL, 2001, 7 (06): : 527 - 527
  • [5] Does Phoenix Failure Definition Apply to EBRT plus HDR Brachytherapy Boost in Prostate Cancer?
    Martin, A. G.
    Vigneault, E.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    Despres, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S415 - S416
  • [6] Outcome and quality of life after HDR brachytherapy in patients with high-risk localized prostate cancer
    Zinkin, H
    Roth, R
    Lo, T
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S53 - S53
  • [7] HDR Brachytherapy Alone for High-Risk Prostate Cancer: A Safe Approach for Patients With Localized Disease?
    Krauss, Daniel J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05): : 1161 - 1162
  • [8] Long-term Experience of HDR Brachytherapy Boost for Localized Prostate Cancer
    Magnan, S.
    Despres, P.
    Martin, A.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    Vigneault, E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S412 - S412
  • [9] Long-Term Outcomes of Patients With High-Risk Prostate Cancer Treated With HDR Brachytherapy Boost
    Chang, A. J.
    Roach, M.
    Gottschalk, A.
    Cunha, A. J.
    Seymour, Z. A.
    Johnson, J. A.
    Raleigh, D.
    Shinohara, K.
    Hsu, I. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S449 - S449
  • [10] HDR Brachytherapy in the Management of High-Risk Prostate Cancer
    Masson, Susan
    Persad, Raj
    Bahl, Amit
    [J]. ADVANCES IN UROLOGY, 2012, 2012
12345